Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Fang, NJ

Carrie H. Fang, Pittstown, NJ US

Patent application numberDescriptionPublished
20080226754METHOD FOR TREATMENT OF CARTILAGE DISORDERS WITH CENTELLA EXTRACT - The invention is a method for the treatment of mammalian articular cartilage disorders, inflammatory joint disease, trauma-related cartilage injuries, and degenerative disc disease. The method involves treating the affected area with a composition containing a therapeutically effective dose of 09-18-2008
20080268016Engineered Renal Tissue - Biocompatible tissue repair implant devices and their methods of use are provided for repairing a diseased kidney tissue. The present invention relates to methods of removing a portion of kidney tissue from a host or donor, mincing it, placing it on a bioresorbable scaffold, and implanting the scaffold into a defect site in a kidney of a host or patient for use in the treatment of degenerative kidney diseases. The compositions and methods provide a pluripotent milieu for the de-novo generation of renal tubular structures in the replacement of diseased kidney tissue. The processes and devices are useful in the treatment of medical conditions and diseases relating to the kidneys such as trauma, necrosis, and both acute and chronic forms of renal failure.10-30-2008
20090155245Treatment for Organ Regeneration with Combination of Drug and Biologics - Combination therapies of drugs and biologics for treatment of acute and chronic organ degeneration are disclosed. More specifically, the use of morphogens, stem cells, and anti-inflammatories or inhibitors for the renin-angiotensin-aldosterone system (RAAS) for the treatment of acute and chronic renal disease is disclosed.06-18-2009
20090162351Transdiscal administration of inhibitors of p38 MAP kinase - The present invention relates to methods, formulations and kits for administering a p38 MAP kinase inhibitor or other therapeutic agent into an intervertebral disc, such as a diseased disc, for example, for purposes of prevention and treatment of degenerative and other disorders.06-25-2009
20090162376Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints - The present invention relates to trans-capsularly administering into a diseased joint an inhibitor of p38 MAP kinase or a different therapeutic agent.06-25-2009
20090275129TISSUE ENGINEERED BLOOD VESSELS - Compositions and methods of using tissue engineered blood vessels to repair and regenerate blood vessels of patients with vascular disease are disclosed.11-05-2009
20110060419MEDICAL DEVICES WITH GALVANIC PARTICULATES - Implantable medical devices having galvanic particulates are disclosed. The particulates may be coated onto at least part of a surface of the medical device. In addition, the galvanic particulates may be contained in the material used to manufacture the antimicrobial medical devices, or may be embedded into the surface of the medical devices. The present invention also provides novel coating methods and processing methods. The devices may have advantageous characteristics and effects including anti-microbial, anti-inflammatory, and tissue regeneration promoting. The medical devices may be used as bone implants.03-10-2011
20110143429TISSUE ENGINEERED BLOOD VESSELS - Compositions and methods of using tissue engineered blood vessels to repair and regenerate blood vessels of patients with vascular disease are disclosed.06-16-2011
20110223205TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING UMBILICAL DERIVED CELLS - This invention relates to methods of treating amyotrophic lateral sclerosis. In particular, the invention provides for methods of treating amyotrophic lateral sclerosis by administering umbilical cord tissue-derived cells, an effective amount of a substantially homogenous population of umbilical cord tissue-derived cells or a pharmaceutical composition comprising umbilical cord tissue-derived cells to a patient.09-15-2011
20110230406AFFINITY PEPTIDES TOWARD BMP-2 - We have disclosed affinity peptides toward BMP-2. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for BMP-2.09-22-2011
20120089232MEDICAL DEVICES WITH GALVANIC PARTICULATES - Implantable medical devices having galvanic particulates are disclosed. The particulates may be coated onto at least part of a surface of the medical device. In addition, the galvanic particulates may be contained in the material used to manufacture the antimicrobial medical devices, or may be embedded into the surface of the medical devices. The present invention also provides novel coating methods and processing methods. The present invention further provides a combination of galvanic particulates with an aqueous gel, a method of making this combination, and a method of treatment using this combination. The devices and compositions may have advantageous characteristics and effects including anti-microbial, anti-inflammatory, tissue regeneration promoting, and pain reduction or elimination.04-12-2012

Patent applications by Carrie H. Fang, Pittstown, NJ US

Howard L. Fang, Bridgewater, NJ US

Patent application numberDescriptionPublished
20120116137SINGLE LOOP MULTISTAGE FUEL PRODUCTION - Synthetic fuels are produced from synthesis gas in a four-stage reactor system with a single recycle loop providing the requisite thermal capacity to moderate the high heat release of the reactions and to provide the reactants and reaction environments for the efficient operation of the process. The first stage converts a portion of the synthesis gas to methanol, the second stage converts the methanol to dimethylether, the third stage converts the methanol and dimethylether to fuel and the fourth stage converts the high melting point component, durene, and other low volatility aromatic components such as tri- andtetra-methylbenzenes to high octane branched paraffins. The four-stage catalyst used for hydrotreating is resistant to CO poisoning. The reactions i produce water as a side product that is carried through to a high pressure separator after the fourth stage. The streams from the separator are a liquid fuel stream, a water stream and a gaseous stream that contains light hydrocarbon gases and the unreacted synthesis gas. The larger part of this gas stream is recycled to the inlet of the first stage and mixed with the fresh synthesis gas stream. Alternatively, the fresh synthetic gas stream is mixed with the product of the second stage. The smaller part of the gas stream from the separator is sent to hydrocarbon recovery and to fuel gas used for providing preheat of various streams. The liquid fuel is sent for blending into fuel products, such as gasoline, jet fuel, or diesel, and the water stream can be sent, for example, to the synthesis gas producing plant for steam generation.05-10-2012

John Fang, Parsippany, NJ US

Patent application numberDescriptionPublished
20100015441POLYMER COMPOSITIONS - Polymers are described that are prepared from di and mono-functional silicone and silane monomers of Formula 1 in which Y represents a direct bond or a oxy group; R01-21-2010

John Z. Fang, Parsippany, NJ US

Patent application numberDescriptionPublished
20110070379LIGHT AND UV STABILISERS - A light stabiliser AS comprising a surface-active or amphiphilic part A which leads to migration of the stabiliser to the surface of a material during the process of formation of a surface, and solidification of the material, and a stabilising part S which is the photochemically active ingredient and transforms the energy of the incident light to vibrational or heat energy that is dissipated within the material, characterised in that both parts are connected by a chemical bond in the form of a single or multiple bond or of an at least divalent bridging group03-24-2011

Larry Yun Fang, Plainsboro, NJ US

Patent application numberDescriptionPublished
20090111831PHARMACEUTICAL COMPOSITIONS - Disclosed herein are novel compositions useful for the treatment of androgen dependant diseases.04-30-2009
20110034478Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAs - The present invention provides a solid molecularly dispersed composition comprising a poorly water soluble and weakly basic azole antifungal compound and a pH sensitive polymer, pharmaceutical compositions, comprising the solid molecularly dispersed composition of the invention and methods of treating and/or preventing a fungal infection in a patient in need thereof comprising orally administering a pharmaceutical composition comprising a composition of the invention to a patient in need thereof. Preferably the antifungal, compound is posaconazole, and the pH sensitive polymer is HPMCAS.02-10-2011
20110123627HIGH DENSITY COMPOSITIONS CONTAINING POSACONAZOLE AND FORMULATIONS COMPRISING THE SAME - The present application provides novel compositions comprising posaconazole and a polymer wherein the composition has a glass transition temperature (Tg) of less than about 1100 C. The application also describes compositions comprising posaconazole and a polymer having a bulk density of greater than about 0.4 mg/mL. The application also describes compositions comprising posaconazole and a polymer which provide an exposure (AUCtf) of at least about 10,000 ng·hr/mL when administered to a patient in a fasted state. The application also describes a novel process for preparing these compositions. The preff erred polymer is HPMCAS. Preferably the composition is an extruded material.05-26-2011

Patent applications by Larry Yun Fang, Plainsboro, NJ US

Ron Fang, Morristown, NJ US

Patent application numberDescriptionPublished
20090109066WIRELESS WHEEL-SENSOR SYSTEM FOR DEAD RECKONING NAVIGATION APPLICATIONS - A dead-reckoning sensory system includes a receiver unit and a transmitter unit in wireless communication with the receiver unit. The transmitter unit is operable to be mounted to a wheel of a vehicle, determine information characterizing the heading and distance traveled by the vehicle, and transmit the information to the receiver unit.04-30-2009

Shu Fang, Plainsboro, NJ US

Patent application numberDescriptionPublished
20110229304Vertical axis wind turbine system - A wind turbine system utilizes three vertical shaft rotor units, each rotor unit consisting of three blades. The rotor units are synchronized such that the blades of each unit are maintained at twenty degree intervals, so as to capture head on wind at maximum efficiency. The front rotor unit comprises baffles which appropriately redirect airflow to the rotor units. A stabilizing fin is provided to ensure that the wind turbine system is always headed into the prevailing wind. The system achieves near one hundred percent efficient use of ongoing ambient wind.09-22-2011

Stacy Fang, Little Falls, NJ US

Patent application numberDescriptionPublished
20090000102Turbine vane restoration system - A system and method for reconfiguring a turbine vane. In at least one embodiment, the system may be used to straighten an airfoil of a turbine vane segment to remove lean, twist, or racking, or any combination thereof. The airfoil may be straightened by fixing portions of the forward and aft hooks of the inner and outer shrouds of the turbine vane, restricting other portions of the forward and aft hooks of the inner and outer shrouds of the turbine vane to only move rotationally about a centerline of the inner or outer shrouds, and applying a load to various portions of the inner and outer shrouds and the airfoil to return the turbine vane to be within predetermined specifications.01-01-2009

Tong Fang, Princeton, NJ US

Patent application numberDescriptionPublished
20090116731Method and system for detection of concha and intertragal notch point in 3D undetailed ear impressions - A method and system for detecting the concha and intertragal notch in an undetailed 3D ear impression is disclosed. The concha is detected by searching vertical scan lines in a region surrounding the aperture using a two-pass method. The intertragal notch is detected based on a bottom contour of the 3D undetailed ear impression and a local coordinate system defined for the 3D undetailed ear impression.05-07-2009

Xinping Fang, Closter, NJ US

Patent application numberDescriptionPublished
200901182483-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof - The invention relates to a novel multi step process of making compounds of Formula I:05-07-2009